{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T21:49:49Z","timestamp":1775771389290,"version":"3.50.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,6,10]],"date-time":"2014-06-10T00:00:00Z","timestamp":1402358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"},{"start":{"date-parts":[[2014,6,10]],"date-time":"2014-06-10T00:00:00Z","timestamp":1402358400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/srep05069","type":"journal-article","created":{"date-parts":[[2014,6,10]],"date-time":"2014-06-10T09:05:37Z","timestamp":1402391137000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["A pharmacoproteomic study confirms the synergistic effect of chondroitin sulfate and glucosamine"],"prefix":"10.1038","volume":"4","author":[{"given":"Valentina","family":"Calamia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas","family":"Mateos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Fern\u00e1ndez-Puente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc\u00eda","family":"Lourido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina","family":"Fern\u00e1ndez-Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eulalia","family":"Montell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep","family":"Verg\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Ruiz-Romero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco J.","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,6,10]]},"reference":[{"key":"BFsrep05069_CR1","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1002\/art.24255","volume":"60","author":"A Kahan","year":"2009","unstructured":"Kahan, A., Uebelhart, D., De Vathaire, F., Delmas, P. D. & Reginster, J. Y. Long-term effects of chondroitins 4 and 6 sulfate on knee osteoarthritis: the study on osteoarthritis progression prevention, a two-year, randomized, double-blind, placebo-controlled trial. Arthritis Rheum 60, 524\u2013533 (2009).","journal-title":"Arthritis Rheum"},{"key":"BFsrep05069_CR2","doi-asserted-by":"publisher","first-page":"573","DOI":"10.2165\/00002512-200724070-00005","volume":"24","author":"O Bruyere","year":"2007","unstructured":"Bruyere, O. & Reginster, J. Y. Glucosamine and chondroitin sulfate as therapeutic agents for knee and hip osteoarthritis. Drugs Aging 24, 573\u2013580 (2007).","journal-title":"Drugs Aging"},{"key":"BFsrep05069_CR3","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1001\/archinte.162.18.2113","volume":"162","author":"K Pavelka","year":"2002","unstructured":"Pavelka, K. et al. Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study. Arch Intern Med 162, 2113\u20132123 (2002).","journal-title":"Arch Intern Med"},{"key":"BFsrep05069_CR4","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S0140-6736(00)03610-2","volume":"357","author":"JY Reginster","year":"2001","unstructured":"Reginster, J. Y. et al. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. Lancet 357, 251\u2013256 (2001).","journal-title":"Lancet"},{"key":"BFsrep05069_CR5","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1177\/1759720X12437753","volume":"4","author":"LC Rovati","year":"2012","unstructured":"Rovati, L. C., Girolami, F. & Persiani, S. Crystalline glucosamine sulfate in the management of knee osteoarthritis: efficacy, safety and pharmacokinetic properties. Ther Adv Musculoskelet Dis 4, 167\u2013180 (2012).","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"BFsrep05069_CR6","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1002\/art.20867","volume":"52","author":"BA Michel","year":"2005","unstructured":"Michel, B. A. et al. Chondroitins 4 and 6 sulfate in osteoarthritis of the knee: a randomized, controlled trial. Arthritis Rheum 52, 779\u2013786 (2005).","journal-title":"Arthritis Rheum"},{"key":"BFsrep05069_CR7","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa052771","volume":"354","author":"DO Clegg","year":"2006","unstructured":"Clegg, D. O. et al. Glucosamine, chondroitin sulfate and the two in combination for painful knee osteoarthritis. N Engl J Med 354, 795\u2013808 (2006).","journal-title":"N Engl J Med"},{"key":"BFsrep05069_CR8","doi-asserted-by":"crossref","unstructured":"Martel-Pelletier, J. et al. First-line analysis of the effects of treatment on progression of structural changes in knee osteoarthritis over 24 months: data from the osteoarthritis initiative progression cohort. Ann Rheum Dis 2013-203906, 10.1136\/annrheumdis-2013-203906 (2013).","DOI":"10.1136\/annrheumdis-2013-203906"},{"key":"BFsrep05069_CR9","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.joca.2010.01.013","volume":"18","author":"W Zhang","year":"2010","unstructured":"Zhang, W. et al. OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage 18, 476\u2013499 (2010).","journal-title":"Osteoarthritis Cartilage"},{"key":"BFsrep05069_CR10","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.2460\/ajvr.2005.66.1870","volume":"66","author":"PS Chan","year":"2005","unstructured":"Chan, P. S., Caron, J. P. & Orth, M. W. Effect of glucosamine and chondroitin sulfate on regulation of gene expression of proteolytic enzymes and their inhibitors in interleukin-1-challenged bovine articular cartilage explants. Am J Vet Res 66, 1870\u20131876 (2005).","journal-title":"Am J Vet Res"},{"key":"BFsrep05069_CR11","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.joca.2005.01.003","volume":"13","author":"PS Chan","year":"2005","unstructured":"Chan, P. S., Caron, J. P., Rosa, G. J. & Orth, M. W. Glucosamine and chondroitin sulfate regulate gene expression and synthesis of nitric oxide and prostaglandin E(2) in articular cartilage explants. Osteoarthritis Cartilage 13, 387\u2013394 (2005).","journal-title":"Osteoarthritis Cartilage"},{"key":"BFsrep05069_CR12","first-page":"1329","volume":"33","author":"PS Chan","year":"2006","unstructured":"Chan, P. S., Caron, J. P. & Orth, M. W. Short-term gene expression changes in cartilage explants stimulated with interleukin beta plus glucosamine and chondroitin sulfate. J Rheumatol 33, 1329\u20131340 (2006).","journal-title":"J Rheumatol"},{"key":"BFsrep05069_CR13","doi-asserted-by":"publisher","first-page":"709","DOI":"10.2460\/ajvr.68.7.709","volume":"68","author":"PS Chan","year":"2007","unstructured":"Chan, P. S., Caron, J. P. & Orth, M. W. Effects of glucosamine and chondroitin sulfate on bovine cartilage explants under long-term culture conditions. Am J Vet Res 68, 709\u2013715 (2007).","journal-title":"Am J Vet Res"},{"key":"BFsrep05069_CR14","doi-asserted-by":"publisher","first-page":"R117","DOI":"10.1186\/ar2325","volume":"9","author":"SK Tat","year":"2007","unstructured":"Tat, S. K. et al. Chondroitin and glucosamine sulfate in combination decrease the pro-resorptive properties of human osteoarthritis subchondral bone osteoblasts: a basic science study. Arthritis Res Ther 9, R117 (2007).","journal-title":"Arthritis Res Ther"},{"key":"BFsrep05069_CR15","doi-asserted-by":"publisher","first-page":"R138","DOI":"10.1186\/ar3077","volume":"12","author":"V Calamia","year":"2010","unstructured":"Calamia, V. et al. Pharmacoproteomic study of the effects of chondroitin and glucosamine sulfate on human articular chondrocytes. Arthritis Res Ther 12, R138 (2010).","journal-title":"Arthritis Res Ther"},{"key":"BFsrep05069_CR16","doi-asserted-by":"publisher","first-page":"R202","DOI":"10.1186\/ar4040","volume":"14","author":"V Calamia","year":"2012","unstructured":"Calamia, V. et al. Secretome analysis of chondroitin sulfate-treated chondrocytes reveals anti-angiogenic, anti-inflammatory and anti-catabolic properties. Arthritis Res Ther 14, R202 (2012).","journal-title":"Arthritis Res Ther"},{"key":"BFsrep05069_CR17","doi-asserted-by":"crossref","unstructured":"Calamia, V. et al. Pharmacoproteomic study of three different chondroitin sulfate compounds on intracellular and extracellular human chondrocyte proteomes. Mol Cell Proteomics 11, M111.013417 (2012).","DOI":"10.1074\/mcp.M111.013417"},{"key":"BFsrep05069_CR18","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1021\/pr060474i","volume":"6","author":"CS Gan","year":"2007","unstructured":"Gan, C. S., Chong, P. K., Pham, T. K. & Wright, P. C. Technical, experimental and biological variations in isobaric tags for relative and absolute quantitation (iTRAQ). J Proteome Res 6, 821\u2013827 (2007).","journal-title":"J Proteome Res"},{"key":"BFsrep05069_CR19","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.3727\/096368910X550215","volume":"20","author":"M Polacek","year":"2011","unstructured":"Polacek, M., Bruun, J. A., Elvenes, J., Figenschau, Y. & Martinez, I. The secretory profiles of cultured human articular chondrocytes and mesenchymal stem cells: implications for autologous cell transplantation strategies. Cell Transplant 20, 1381\u20131393 (2011).","journal-title":"Cell Transplant"},{"key":"BFsrep05069_CR20","doi-asserted-by":"publisher","first-page":"3701","DOI":"10.1021\/pr200331k","volume":"10","author":"V Calamia","year":"2011","unstructured":"Calamia, V. et al. Metabolic labeling of chondrocytes for the quantitative analysis of the interleukin-1-beta-mediated modulation of their intracellular and extracellular proteomes. J Proteome Res 10, 3701\u20133711 (2011).","journal-title":"J Proteome Res"},{"key":"BFsrep05069_CR21","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1074\/mcp.M000014-MCP201","volume":"9","author":"R Wilson","year":"2010","unstructured":"Wilson, R. et al. Comprehensive profiling of cartilage extracellular matrix formation and maturation using sequential extraction and label-free quantitative proteomics. Mol Cell Proteomics 9, 1296\u20131313 (2010).","journal-title":"Mol Cell Proteomics"},{"key":"BFsrep05069_CR22","doi-asserted-by":"publisher","first-page":"18913","DOI":"10.1074\/jbc.M111.298968","volume":"287","author":"P \u00d6nnerfjord","year":"2012","unstructured":"\u00d6nnerfjord, P., Khabut, A., Reinholt, F. P., Svensson, O. & Heineg\u00e5rd, D. Quantitative proteomic analysis of eight cartilaginous tissues reveals characteristic differences as well as similarities between subgroups. J Biol Chem 287, 18913\u201318924 (2012).","journal-title":"J Biol Chem"},{"key":"BFsrep05069_CR23","doi-asserted-by":"crossref","unstructured":"Wilson, R. et al. Changes in the chondrocyte and extracellular matrix proteome during post-natal mouse cartilage development. Mol Cell Proteomics 11, M111.014159 (2012).","DOI":"10.1074\/mcp.M111.014159"},{"key":"BFsrep05069_CR24","doi-asserted-by":"publisher","first-page":"3262","DOI":"10.1002\/pmic.201000093","volume":"10","author":"JA Medina-Aunon","year":"2010","unstructured":"Medina-Aunon, J. A. et al. Protein Information and Knowledge Extractor: Discovering biological information from proteomics data. Proteomics 10, 3262\u20133271 (2010).","journal-title":"Proteomics"},{"key":"BFsrep05069_CR25","doi-asserted-by":"publisher","first-page":"5350","DOI":"10.1021\/pr300572r","volume":"11","author":"B Rocha","year":"2012","unstructured":"Rocha, B. et al. Metabolic labeling of human bone marrow mesenchymal stem cells for the quantitative analysis of their chondrogenic differentiation. J Proteome Res 11, 5350\u20135361 (2012).","journal-title":"J Proteome Res"},{"key":"BFsrep05069_CR26","doi-asserted-by":"publisher","first-page":"5095","DOI":"10.1021\/pr200695p","volume":"10","author":"P Fern\u00e1ndez-Puente","year":"2011","unstructured":"Fern\u00e1ndez-Puente, P. et al. Identification of a panel of novel serum osteoarthritis biomarkers. J Proteome Res 10, 5095\u20135101 (2011).","journal-title":"J Proteome Res"},{"key":"BFsrep05069_CR27","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1074\/mcp.M800292-MCP200","volume":"8","author":"C Ruiz-Romero","year":"2009","unstructured":"Ruiz-Romero, C. et al. Mitochondrial dysregulation of osteoarthritic human articular chondrocytes analyzed by proteomics: a decrease in mitochondrial superoxide dismutase points to a redox imbalance. Mol Cell Proteomics 8, 172\u2013189 (2009).","journal-title":"Mol Cell Proteomics"},{"key":"BFsrep05069_CR28","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1002\/pmic.200700249","volume":"8","author":"C Ruiz-Romero","year":"2008","unstructured":"Ruiz-Romero, C. et al. Proteomic analysis of human osteoarthritic chondrocytes reveals protein changes in stress and glycolysis. Proteomics 8, 495\u2013507 (2008).","journal-title":"Proteomics"},{"key":"BFsrep05069_CR29","first-page":"1125","volume":"19","author":"N Cap\u00edn-Guti\u00e9rrez","year":"2004","unstructured":"Cap\u00edn-Guti\u00e9rrez, N., Talam\u00e1s-Rohana, P., Gonz\u00e1lez-Robles, A., Lavalle-Montalvo, C. & Kour\u00ed, J. B. Cytoskeleton disruption in chondrocytes from a rat osteoarthrosic (OA) -induced model: its potential role in OA pathogenesis. Histol Histopathol 19, 1125\u20131132 (2004).","journal-title":"Histol Histopathol"},{"key":"BFsrep05069_CR30","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.joca.2007.06.005","volume":"16","author":"S Lambrecht","year":"2008","unstructured":"Lambrecht, S., Verbruggen, G., Verdonk, P. C., Elewaut, D. & Deforce, D. Differential proteome analysis of normal and osteoarthritic chondrocytes reveals distortion of vimentin network in osteoarthritis. Osteoarthritis Cartilage 16, 163\u2013173 (2008).","journal-title":"Osteoarthritis Cartilage"},{"key":"BFsrep05069_CR31","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/1471-2474-12-237","volume":"12","author":"V Calamia","year":"2011","unstructured":"Calamia, V., de Andr\u00e9s, M. C., Oreiro, N., Ruiz-Romero, C. & Blanco, F. J. Hsp90\u03b2 inhibition modulates nitric oxide production and nitric oxide-induced apoptosis in human chondrocytes. BMC Musculoskelet Disord 12, 237 (2011).","journal-title":"BMC Musculoskelet Disord"},{"key":"BFsrep05069_CR32","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1002\/art.22664","volume":"56","author":"AK Boehm","year":"2007","unstructured":"Boehm, A. K., Seth, M., Mayr, K. G. & Fortier, L. A. Hsp90 mediates insulin-like growth factor 1 and interleukin-1beta signaling in an age-dependent manner in equine articular chondrocytes. Arthritis Rheum 56, 2335\u20132343 (2007).","journal-title":"Arthritis Rheum"},{"key":"BFsrep05069_CR33","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1053\/joca.1998.0112","volume":"6","author":"CT Bassleer","year":"1998","unstructured":"Bassleer, C. T., Combal, J. P., Bougaret, S. & Malaise, M. Effects of chondroitin sulfate and interleukin-1 beta on human articular chondrocytes cultivated in clusters. Osteoarthritis Cartilage 6, 196\u2013204 (1998).","journal-title":"Osteoarthritis Cartilage"},{"key":"BFsrep05069_CR34","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1248\/bpb.33.410","volume":"33","author":"K Imada","year":"2010","unstructured":"Imada, K. et al. Anti-arthritic action mechanisms of natural chondroitin sulfate in human articular chondrocytes and synovial fibroblasts. Biol Pharm Bull 33, 410\u2013414 (2010).","journal-title":"Biol Pharm Bull"},{"key":"BFsrep05069_CR35","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1136\/ard.2009.120469","volume":"69","author":"AD Sawitzke","year":"2010","unstructured":"Sawitzke, A. D. et al. Clinical efficacy and safety of glucosamine, chondroitin sulphate, their combination, celecoxib or placebo taken to treat osteoarthritis of the knee: 2-year results from GAIT. Ann Rheum Dis 69, 1459\u20131464 (2010).","journal-title":"Ann Rheum Dis"},{"key":"BFsrep05069_CR36","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1177\/147323000803600602","volume":"36","author":"EC Huskisson","year":"2008","unstructured":"Huskisson, E. C. Glucosamine and chondroitin for osteoarthritis. J Int Med Res 36, 1161\u20131179 (2008).","journal-title":"J Int Med Res"},{"key":"BFsrep05069_CR37","doi-asserted-by":"crossref","unstructured":"Lippiello, L., Woodward, J., Karpman, R. & Hammad, T. A. In vivo chondroprotection and metabolic synergy of glucosamine and chondroitin sulfate. Clin Orthop Relat Res, 229\u2013240 (2000).","DOI":"10.1097\/00003086-200012000-00027"},{"key":"BFsrep05069_CR38","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S1063-4584(03)00026-8","volume":"11","author":"L Lippiello","year":"2003","unstructured":"Lippiello, L. Glucosamine and chondroitin sulfate: biological response modifiers of chondrocytes under simulated conditions of joint stress. Osteoarthritis Cartilage 11, 335\u2013342 (2003).","journal-title":"Osteoarthritis Cartilage"},{"key":"BFsrep05069_CR39","doi-asserted-by":"crossref","unstructured":"Orth, M. W., Peters, T. L. & Hawkins, J. N. Inhibition of articular cartilage degradation by glucosamine-HCl and chondroitin sulphate. Equine Vet J Suppl 224\u2013229 (2002).","DOI":"10.1111\/j.2042-3306.2002.tb05423.x"},{"key":"BFsrep05069_CR40","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s11926-013-0361-z","volume":"15","author":"Y Henrotin","year":"2013","unstructured":"Henrotin, Y. & Lambert, C. Chondroitin and glucosamine in the management of osteoarthritis: an update. Curr Rheumatol Rep 15, 361 (2013).","journal-title":"Curr Rheumatol Rep"},{"key":"BFsrep05069_CR41","doi-asserted-by":"crossref","unstructured":"du Souich, P. Absorption, distribution and mechanism of action of SYSADOAS. Pharmacol Ther (2014).","DOI":"10.1016\/j.pharmthera.2014.01.002"},{"key":"BFsrep05069_CR42","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1177\/1759720X10383076","volume":"2","author":"Y Henrotin","year":"2010","unstructured":"Henrotin, Y., Mathy, M., Sanchez, C. & Lambert, C. Chondroitin sulfate in the treatment of osteoarthritis: from in vitro studies to clinical recommendations. Ther Adv Musculoskelet Dis 2, 335\u2013348 (2010).","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"BFsrep05069_CR43","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/S1063-4584(98)80006-X","volume":"6 Suppl A","author":"F Ronca","year":"1998","unstructured":"Ronca, F., Palmieri, L., Panicucci, P. & Ronca, G. Anti-inflammatory activity of chondroitin sulfate. Osteoarthritis Cartilage 6 Suppl A, 14\u201321 (1998).","journal-title":"Osteoarthritis Cartilage"},{"key":"BFsrep05069_CR44","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.nucmedbio.2013.07.007","volume":"40","author":"G Sobal","year":"2013","unstructured":"Sobal, G., Dorotka, R., Menzel, J. & Sinzinger, H. Uptake studies with chondrotropic 99mTc-chondroitin sulfate in articular cartilage. Implications for imaging osteoarthritis in the knee. Nucl Med Biol 40, 1013\u20131017 (2013).","journal-title":"Nucl Med Biol"},{"key":"BFsrep05069_CR45","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.nucmedbio.2008.10.013","volume":"36","author":"G Sobal","year":"2009","unstructured":"Sobal, G., Menzel, J. & Sinzinger, H. Uptake of 99mTc-labeled chondroitin sulfate by chondrocytes and cartilage: a promising agent for imaging of cartilage degeneration. Nucl Med Biol 36, 65\u201371 (2009).","journal-title":"Nucl Med Biol"},{"key":"BFsrep05069_CR46","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1021\/mp300432s","volume":"10","author":"YL Lo","year":"2013","unstructured":"Lo, Y. L., Sung, K. H., Chiu, C. C. & Wang, L. F. Chemically conjugating polyethylenimine with chondroitin sulfate to promote CD44-mediated endocytosis for gene delivery. Mol Pharm 10, 664\u2013676 (2013).","journal-title":"Mol Pharm"},{"key":"BFsrep05069_CR47","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1093\/intimm\/13.3.359","volume":"13","author":"T Fujimoto","year":"2001","unstructured":"Fujimoto, T. et al. CD44 binds a chondroitin sulfate proteoglycan, aggrecan. Int Immunol 13, 359\u2013366 (2001).","journal-title":"Int Immunol"},{"key":"BFsrep05069_CR48","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.joca.2007.05.020","volume":"16","author":"F Legendre","year":"2008","unstructured":"Legendre, F., Baug\u00e9, C., Roche, R., Saurel, A. S. & Pujol, J. P. Chondroitin sulfate modulation of matrix and inflammatory gene expression in IL-1beta-stimulated chondrocytes--study in hypoxic alginate bead cultures. Osteoarthritis Cartilage 16, 105\u2013114 (2008).","journal-title":"Osteoarthritis Cartilage"},{"key":"BFsrep05069_CR49","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.abb.2009.09.017","volume":"491","author":"GM Campo","year":"2009","unstructured":"Campo, G. M. et al. Glycosaminoglycans reduced inflammatory response by modulating toll-like receptor-4 in LPS-stimulated chondrocytes. Arch Biochem Biophys 491, 7\u201315 (2009).","journal-title":"Arch Biochem Biophys"},{"key":"BFsrep05069_CR50","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1053\/joca.1999.0306","volume":"8","author":"AM DeLise","year":"2000","unstructured":"DeLise, A. M., Fischer, L. & Tuan, R. S. Cellular interactions and signaling in cartilage development. Osteoarthritis Cartilage 8, 309\u2013334 (2000).","journal-title":"Osteoarthritis Cartilage"},{"key":"BFsrep05069_CR51","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1016\/j.actbio.2012.03.021","volume":"8","author":"V Hintze","year":"2012","unstructured":"Hintze, V. et al. Sulfated hyaluronan and chondroitin sulfate derivatives interact differently with human transforming growth factor-\u03b21 (TGF-\u03b21). Acta Biomater 8, 2144\u20132152 (2012).","journal-title":"Acta Biomater"},{"key":"BFsrep05069_CR52","doi-asserted-by":"publisher","first-page":"5007","DOI":"10.1016\/j.biomaterials.2013.03.037","volume":"34","author":"JJ Lim","year":"2013","unstructured":"Lim, J. J. & Temenoff, J. S. The effect of desulfation of chondroitin sulfate on interactions with positively charged growth factors and upregulation of cartilaginous markers in encapsulated MSCs. Biomaterials 34, 5007\u20135018 (2013).","journal-title":"Biomaterials"},{"key":"BFsrep05069_CR53","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.fct.2004.11.006","volume":"43","author":"JW Anderson","year":"2005","unstructured":"Anderson, J. W., Nicolosi, R. J. & Borzelleca, J. F. Glucosamine effects in humans: a review of effects on glucose metabolism, side effects, safety considerations and efficacy. Food Chem Toxicol 43, 187\u2013201 (2005).","journal-title":"Food Chem Toxicol"},{"key":"BFsrep05069_CR54","doi-asserted-by":"publisher","first-page":"R104","DOI":"10.1186\/ar2307","volume":"9","author":"AS d'Abusco","year":"2007","unstructured":"d'Abusco, A. S. et al. Glucosamine affects intracellular signalling through inhibition of mitogen-activated protein kinase phosphorylation in human chondrocytes. Arthritis Res Ther 9, R104 (2007).","journal-title":"Arthritis Res Ther"},{"key":"BFsrep05069_CR55","doi-asserted-by":"publisher","first-page":"R18","DOI":"10.1186\/ar2920","volume":"12","author":"A Scotto d'Abusco","year":"2010","unstructured":"Scotto d'Abusco, A., Politi, L., Giordano, C. & Scandurra, R. A peptidyl-glucosamine derivative affects IKKalpha kinase activity in human chondrocytes. Arthritis Res Ther 12, R18 (2010).","journal-title":"Arthritis Res Ther"},{"key":"BFsrep05069_CR56","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.1002\/pmic.200402106","volume":"5","author":"C Ruiz-Romero","year":"2005","unstructured":"Ruiz-Romero, C., L\u00f3pez-Armada, M. J. & Blanco, F. J. Proteomic characterization of human normal articular chondrocytes: a novel tool for the study of osteoarthritis and other rheumatic diseases. Proteomics 5, 3048\u20133059 (2005).","journal-title":"Proteomics"},{"key":"BFsrep05069_CR57","doi-asserted-by":"publisher","first-page":"656","DOI":"10.3899\/jrheum.090696","volume":"37","author":"SK Tat","year":"2010","unstructured":"Tat, S. K., Pelletier, J. P., Mineau, F., Duval, N. & Martel-Pelletier, J. Variable effects of 3 different chondroitin sulfate compounds on human osteoarthritic cartilage\/chondrocytes: relevance of purity and production process. J Rheumatol 37, 656\u2013664 (2010).","journal-title":"J Rheumatol"},{"key":"BFsrep05069_CR58","doi-asserted-by":"publisher","first-page":"168602","DOI":"10.1155\/2012\/168602","volume":"2012","author":"J Jin","year":"2012","unstructured":"Jin, J. et al. Differential proteome profiling using iTRAQ in microalbuminuric and normoalbuminuric type 2 diabetic patients. Exp Diabetes Res 2012, 168602 (2012).","journal-title":"Exp Diabetes Res"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep05069.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep05069","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep05069.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T07:39:35Z","timestamp":1672990775000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep05069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,10]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,12,17]]}},"alternative-id":["BFsrep05069"],"URL":"https:\/\/doi.org\/10.1038\/srep05069","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,10]]},"assertion":[{"value":"28 November 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Eul\u00e0lia Montell is the Head of the Medical Area from Bioib\u00e9rica, SA. Josep Verg\u00e9s is Medical Director of Bioib\u00e9rica, SA. Francisco J. Blanco received a grant from Bioib\u00e9rica, SA to carry out this project. The authors declare no other competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5069"}}